BioInvent International
Pre-clinicalBioInvent is a clinical-stage company that discovers and develops antibodies for cancer therapy. Based on extensive knowledge in immunology, cancer biology and antibody biology, BioInvent generates innovative immuno-oncology drug candidates.
Founded
1988
Focus
AntibodiesBiologics
About
BioInvent is a clinical-stage company that discovers and develops antibodies for cancer therapy. Based on extensive knowledge in immunology, cancer biology and antibody biology, BioInvent generates innovative immuno-oncology drug candidates.
Funding History
6Total raised: $77.5M
Grant$2.5MHorizon 2020Jun 15, 2021
Series B$15MUndisclosedJun 15, 2010
Grant$5MEuropean UnionJun 15, 2005
IPO$20MUndisclosedJun 15, 2001
Company Info
TypePrivate
Founded1988
LocationLund, Sweden
StagePre-clinical
Contact
SIMILAR COMPANIES
Basic Genomics
Pre-clinical · Stockholm
2A Pharma
Phase 1 · Stockholm
Abliva
Pre-clinical · Lund
Affibody
Phase 1 · Solna
Alligator Bioscience
Phase 1 · Lund
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile